AA
LVACW

Ancora Advisors’s LAVA Medtech Acquisition Corp. Warrants LVACW Stock Holding History

Ancora Advisors’s Portfolio LVACW Stock Details LVACW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,704
Closed -$143 – 1985
2023
Q1 		$143 Hold
1,704
– – ﹤0.01% 1867
2022
Q4 		$0 Hold
1,704
– – ﹤0.01% 2211
2022
Q3 		$0 Hold
1,704
– – ﹤0.01% 2353
2022
Q2 		$0 Hold
1,704
– – ﹤0.01% 2513
2022
Q1 		$1K Buy
+1,704
New +$690 ﹤0.01% 2331

Ancora Advisors's LVACW Position: Q2 2023 in Review

Ancora Advisors sold out of LAVA Medtech Acquisition Corp. Warrants (LVACW) in Q2 2023, closing a stake of 1,704 shares — an estimated $143 sold.

Ancora Advisors first reported a position in LVACW in Q1 2022 and held it in 5 quarters. The position peaked at $1K in Q1 2022. 0 funds tracked by Wall St. Rank hold LVACW as of Q2 2023.

  • Ancora Advisors reported no remaining LAVA Medtech Acquisition Corp. Warrants position as of Q2 2023 after selling out during the quarter.
  • Ancora Advisors sold 1,704 LAVA Medtech Acquisition Corp. Warrants shares in Q2 2023, an estimated $143.
  • Ancora Advisors first reported a position in LAVA Medtech Acquisition Corp. Warrants in Q1 2022 and held it in 5 quarters.
  • Ancora Advisors's LAVA Medtech Acquisition Corp. Warrants position peaked at $1K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Warrants as of Q2 2023.

Based on Ancora Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.